Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Dianthus Therapeutics, Inc. (DNTH) had Weighted-Average Shares Outstanding (Diluted) of 56.03M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.76M |
|
$-50.22M |
|
-- |
|
$0.76M |
|
$62.24M |
|
$-61.48M |
|
$11.27M |
|
$-50.22M |
|
$-50.32M |
|
$-50.22M |
|
$-50.22M |
|
$-50.22M |
|
$-50.32M |
|
$-61.48M |
|
$-67.03M |
|
56.03M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
56.03M |
$-0.90 |
|
$-0.90 |
|
| Balance Sheet Financials | |
$897.54M |
|
$0.42M |
|
$315.73M |
|
$1.21B |
|
$34.39M |
|
-- |
|
$6.86M |
|
$41.25M |
|
$1.17B |
|
$1.17B |
|
$1.17B |
|
54.80M |
|
| Cash Flow Statement Financials | |
$-77.84M |
|
$-612.49M |
|
$749.79M |
|
$51.25M |
|
$110.72M |
|
$59.46M |
|
$22.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
26.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-8079.11% |
|
-8079.11% |
|
-- |
|
-6598.56% |
|
-6598.56% |
|
$-78.03M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
7.18 |
|
12.54 |
|
-4.28% |
|
-4.28% |
|
-4.14% |
|
-4.28% |
|
$21.39 |
|
$-1.39 |
|
$-1.39 |
|